NCT01323920
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.
NCT01323920
NCT00321880
NCT00448201
NCT00499785
NCT00376922
NCT00376987
NCT00534001
NCT00513474
NCT00898261
Not specified
NCT01385150
Not specified